| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Lonial Sagar is a Director at TGTX. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $4.8M at current prices.
Our model assigns Lonial Sagar a below-average insider score of 35/100, based on 6 past trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -55.2%.
Lonial Sagar's largest disclosed position is in TGTX as Director, worth about $4.8M. The recent filings there lean toward selling, a net 91,639 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | TGTX Tg Therapeutics, Inc. | Director | Sell | 20,852 | $32.24 | $672,268.48 | -18.1% | -5.7% | - | |
| Nov 11, 2024 | TGTX Tg Therapeutics, Inc. | Director | Sell | 5,000 | $30.44 | $152,200.00 | -4.8% | +4.9% | +1.2% | |
| Jun 20, 2024 | TGTX Tg Therapeutics, Inc. | Director | Sell | 25,933 | $16.69 | $432,888.91 | -11.3% | +48.7% | +112.1% | |
| Mar 13, 2024 | TGTX Tg Therapeutics, Inc. | Director | Sell | 5,000 | $15.94 | $79,675.00 | -4.4% | +2.7% | +135.6% | |
| Jun 23, 2023 | TGTX Tg Therapeutics, Inc. | Director | Sell | 34,854 | $23.37 | $814,537.98 | -27.1% | -60.8% | -25.2% |